West Pharmaceutical Services (WST) Interest & Investment Income (2009 - 2026)

West Pharmaceutical Services has disclosed Interest & Investment Income across 18 years of filings, most recently posting $5.1 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $5.1 million, up 24.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.5 million (up 5.71% YoY), and the FY2025 annual result was $17.5 million, down 10.71% from the prior year.
• Interest & Investment Income came in at $5.1 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $5.1 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $9.4 million in Q4 2023 to a low of $300000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $4.7 million (2025), against an average of $4.4 million.
• Across the five-year window, Interest & Investment Income jumped 1500.0% in 2023 and sank 48.94% in 2024, its largest moves.
• West Pharmaceutical Services' Interest & Investment Income stood at $2.9 million in 2022, then jumped by 224.14% to $9.4 million in 2023, then tumbled by 48.94% to $4.8 million in 2024, then rose by 6.25% to $5.1 million in 2025, then changed by 0.0% to $5.1 million in 2026.
• The last three Interest & Investment Income figures came in at $5.1 million (Q1 2026), $5.1 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.